Globus Medical Inc (GMED) Stock Price, Quote & News

Company Profile

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary...

Industry: Medical Devices

Sector: Healthcare

Phone: 610 930 1800

Website: www.globusmedical.com

Address:

2560 General Armistead Avenue, Audubon, United States

nycowboy Jul. 17 at 4:58 PM

$GMED She's a sleeper...

0 · Reply

ZacksResearch Jul. 16 at 1:50 PM

$GMED launches DuraPro — is this the next growth driver? The new oscillating system debuts with Excelsius integration, strengthening Globus Medical’s Power Portfolio. Full story here 👉 https://www.zacks.com/stock/news/2585590/gmed-unveils-next-gen-oscillating-system-durapro-stock-to-gain?cid=sm-stocktwits-2-2585590-teaser-2020&ADID=SYND_STOCKTWITS_TWEET_2_2585590_TEASER_2020

0 · Reply

nycowboy Jul. 16 at 10:12 AM

$GMED Granny says the big boys are getting ready to pump this bigly

0 · Reply

Diverstj981 Jul. 15 at 1:00 PM

$GMED

0 · Reply

nycowboy Jul. 15 at 11:16 AM

$GMED Granny says she's primed to run..giddy up

0 · Reply

JarvisFlow Jul. 10 at 1:15 PM

BTIG updates rating for Globus Medical ( $GMED ) to Buy, target set at 91 → 94.

0 · Reply

nycowboy Jul. 7 at 4:13 PM

$GMED Granny says they beat this one down to where we need to BUY as much as we can..

0 · Reply

Diverstj981 Jul. 2 at 4:32 PM

$GMED uggghh. What a pig this is.

0 · Reply

ZacksResearch Jul. 1 at 5:27 PM

$ISRG’s Q1: A Strong Report Amid Rising Competition 🤔 📈 Revenues up 19% YoY, EPS beat expectations 🏥 Over 10,000 global system installs, but facing policy-driven budget cuts in key international markets 🤖 MDT's Hugo is heating up the MIS robotics competition, while $GMED's ExcelsiusGPS is making waves in spinal and cranial procedures See what this means for ISRG’s future dominance 👉 https://www.zacks.com/commentary/2559230/can-isrg-maintain-robotics-edge-amid-rising-rivalry-budget-strain?cid=sm-stocktwits-2-2559230-body-498&ADID=SYND_STOCKTWITS_TWEET_2_2559230_BODY_498

0 · Reply

OptionRunners Jun. 26 at 6:49 PM

$GMED Buyer of the August 15th $57.50 calls (ITM) 500 times for $3.90-$4.00

0 · Reply

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

Jul 3, 2025, 12:10 PM EDT - 14 days ago

Globus Medical: Obtaining My Backing Again

May 15, 2025, 4:30 PM EDT - 2 months ago

Globus Medical Announces $500 Million Share Repurchase Program

May 13, 2025, 6:28 PM EDT - 2 months ago

Medical, Inc. Company Investigated by the Portnoy Law Firm

May 8, 2025, 10:32 PM EDT - 2 months ago

Globus Medical, Inc. (GMED) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:15 PM EDT - 2 months ago

Globus Medical Reports First Quarter 2025 Results

Apr 17, 2025, 4:30 PM EDT - 3 months ago

Globus Medical Schedules First Quarter Earnings Release and Conference Call

Apr 3, 2025, 8:31 AM EDT - 3 months ago

Globus Medical completes acquisition of Nevro Corp.

Mar 21, 2025, 11:30 AM EDT - 4 months ago

NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO

NVRO

Mar 11, 2025, 4:40 PM EDT - 4 months ago

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

Mar 6, 2025, 4:40 PM EST - 4 months ago

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

Mar 5, 2025, 7:01 PM EST - 4 months ago

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Mar 4, 2025, 4:15 PM EST - 4 months ago

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

NVRO

Feb 20, 2025, 9:54 PM EST - 5 months ago

Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:15 PM EST - 5 months ago

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

Feb 6, 2025, 9:30 AM EST - 5 months ago

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

Feb 5, 2025, 6:57 AM EST - 5 months ago

Top 2 Health Care Stocks That May Crash In February

OFIX

Jan 30, 2025, 4:35 PM EST - 6 months ago

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Jan 8, 2025, 4:30 PM EST - 6 months ago

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Jan 8, 2025, 12:10 PM EST - 6 months ago

The Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors

Dec 16, 2024, 1:32 PM EST - 7 months ago

Four hidden gems in the stock market from a five-star fund manager

CARG PGNY TXRH

Nov 22, 2024, 4:30 PM EST - 8 months ago

Globus Medical Launches ExcelsiusHub™ Navigation System

Nov 5, 2024, 8:12 PM EST - 9 months ago

Globus Medical, Inc. (GMED) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 4:15 PM EST - 9 months ago

Globus Medical Reports Third Quarter 2024 Results

Nov 3, 2024, 11:00 AM EST - 9 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Globus Medical Inc For Securities Fraud

Oct 30, 2024, 11:00 AM EDT - 9 months ago

Globus Medical, Inc. Is Being Investigated For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Oct 22, 2024, 11:00 AM EDT - 9 months ago

Globus Medical, Inc. Is Being Investigated For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

Oct 21, 2024, 11:00 AM EDT - 9 months ago

The Schall Law Firm Encourages Investors To Join An Inquiry Into Globus Medical Inc For Possible Securities Fraud

nycowboy Jul. 17 at 4:58 PM

$GMED She's a sleeper...

0 · Reply

ZacksResearch Jul. 16 at 1:50 PM

0 · Reply

nycowboy Jul. 16 at 10:12 AM

$GMED Granny says the big boys are getting ready to pump this bigly

0 · Reply

Diverstj981 Jul. 15 at 1:00 PM

$GMED

0 · Reply

nycowboy Jul. 15 at 11:16 AM

$GMED Granny says she's primed to run..giddy up

0 · Reply

JarvisFlow Jul. 10 at 1:15 PM

BTIG updates rating for Globus Medical ( $GMED ) to Buy, target set at 91 → 94.

0 · Reply

nycowboy Jul. 7 at 4:13 PM

$GMED Granny says they beat this one down to where we need to BUY as much as we can..

0 · Reply

Diverstj981 Jul. 2 at 4:32 PM

$GMED uggghh. What a pig this is.

0 · Reply

ZacksResearch Jul. 1 at 5:27 PM

0 · Reply

OptionRunners Jun. 26 at 6:49 PM

$GMED Buyer of the August 15th $57.50 calls (ITM) 500 times for $3.90-$4.00

0 · Reply

A1FinancialCEOMark Jun. 24 at 1:09 PM

$MDT $ACON The Aclarion Buy Out talk we made a video on, well... is now officially ON. We chose MDT as our pick of the 11 suitors, and NOW here's why we were RIGHT-- Just announced today: Medtronic, Aclarion's CEO Brent Ness, formerly in Medtronic management, to present, & meet-- with $GMED, $OFIX, & $ATEC in CABO tomorrow: Read the full story why top Analysts give Aclarion a $481 pt: https://www.a1loansusa.com/aclarion-at-spine-conference

1 · Reply

BioTechHealthX Jun. 8 at 4:16 AM

$GMED Globus Medical just posted record cash flow and is debt-free. With robotics, AI, and a $2.9B revenue target, this company is flying under the radar.https://biotechhealthx.com/biotech-news/wall-street-is-sleeping-on-globus-medical-gmed-heres-why-you-shouldnt/

0 · Reply

JarvisFlow Jun. 4 at 12:30 PM

Barclays has updated their rating for Globus Medical ( $GMED ) to Overweight with a price target of 100.

0 · Reply

Diverstj981 Jun. 2 at 5:46 PM

$GMED Officially redesignated

0 · Reply

wahoowa96 May. 30 at 7:46 AM

$GMED "While not as large as Intuitive or as diversified as Stryker or Medtronic, Globus is starting to dominate the spine/musculoskeletal niche, and the coming merger should only reinforce this trend. Considering its lower valuation ratio, this might be a good pick for value investors looking for a cheaper stock with still a high-quality profile and strong growth." https://www.securities.io/top-5-robotic-surgery-stock/

0 · Reply

JarvisFlow May. 27 at 1:13 PM

JMP Securities has adjusted their stance on Globus Medical ( $GMED ), setting the rating to Market Perform.

0 · Reply

JarvisFlow May. 27 at 12:00 PM

BTIG has adjusted their stance on Globus Medical ( $GMED ), setting the rating to Neutral.

0 · Reply

OpenOutcrier May. 16 at 12:22 PM

$GMED (+2.7% pre) Globus Medical Announces Massive $500M Share Repurchase: Management Signals Stock Undervalued https://ooc.bz/l/65081

0 · Reply

Rage_Against_The_Machine May. 15 at 8:46 PM

$GMED announces a $500M buyback, claiming shares are undervalued after a 17% post-earnings drop. CFO Pfeil cites confidence in 'intrinsic value,' but with cash reserves down 41% QoQ to $461M, this looks more like a life raft than a growth signal. Execution risk remains high with 1,240 days of inventory. https://www.sec.gov/Archives/edgar/data/1237831/000156276225000131/gmed-20250515x8k.htm

0 · Reply

DonCorleone77 May. 15 at 8:34 PM

$GMED Globus Medical announces $500M share repurchase program Globus Medical announced that its board of directors has authorized a share repurchase program of up to $500M of the company's outstanding common stock.

0 · Reply

Puddlepiratetrading May. 14 at 4:09 PM

$GMED probably needs catalysts but the way it’s holding tightly in this channel is a good sign. Still holding sept 55s

0 · Reply

Puddlepiratetrading May. 12 at 6:34 PM

$GMED trading at nearly 1 times price to book, debt free, 5x revenue, raised free cash flow. Love a good sleeper trade that is not crowded

0 · Reply

Market Cap	7.66B
Revenue (ttm)	2.52B
Net Income (ttm)	102.98M
EPS (ttm)	N/A
PE Ratio	18.02
Forward PE	17.55
Profit Margin	4.09%
Debt to Equity Ratio	0.00

Volume	1,002,400
Avg Vol	1,668,544
Day's Range	N/A - N/A
Shares Out	135.38M
Stochastic %K	61%
Beta	1.19
Analysts	Strong Sell
Price Target	$86.82